James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.

Article  Google Scholar 

Hoy DG, Smith E, Cross M, Sanchez-Riera L, Blyth FM, Buchbinder R, et al. Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the Global Burden of Disease 2010 Study and the next steps forward. Ann Rheum Dis. 2015;74:4–7.

Article  PubMed  Google Scholar 

Luoma K, Riihimäki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A. Low back pain in relation to lumbar disc degeneration. Spine. 2000;25:487–92.

Article  CAS  PubMed  Google Scholar 

Brinjikji W, Diehn FE, Jarvik JG, Carr CM, Kallmes DF, Murad MH, et al. MRI Findings of Disc Degeneration are More Prevalent in Adults with Low Back Pain than in Asymptomatic Controls: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2015;36:2394–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018:391:2368–83.

Nachemson AL, Schultz AB, Berkson MH. Mechanical properties of human lumbar spine motion segments. Influence of age, sex, disc level, and degeneration. Spine. 1979;4:1–8.

Article  CAS  PubMed  Google Scholar 

Urban JPG. The role of the physicochemical environment in determining disc cell behaviour. Biochem Soc Trans. 2002;30:858–64.

Article  CAS  PubMed  Google Scholar 

Setton LA, Chen J. Cell mechanics and mechanobiology in the intervertebral disc. Spine. 2004;29:2710–23.

Article  PubMed  Google Scholar 

Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 2007;35:652–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17635113.

Inkinen RI, Lammi MJ, Lehmonen S, Puustjärvi K, Kääpä E, Tammi MI. Relative increase of biglycan and decorin and altered chondroitin sulfate epitopes in the degenerating human intervertebral disc. J Rheumatol. 1998;25:506–14.

CAS  PubMed  Google Scholar 

Cs-Szabo G, Ragasa-San Juan D, Turumella V, Masuda K, Thonar EJ-MA, An HS. Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. Spine. 2002;27:2212–9.

Article  PubMed  Google Scholar 

Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deakin JA, Buttle DJ, et al. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum. 2009;60:482–91.

Article  CAS  PubMed  Google Scholar 

Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004;204:47–54. http://doi.wiley.com/10.1002/path.1608.

Le Maitre CL, Freemont AJ, Hoyland JA. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007;9:R45.

Article  PubMed  PubMed Central  Google Scholar 

Roberts S, Evans EH, Kletsas D, Jaffray DC, Eisenstein SM. Senescence in human intervertebral discs. Eur Spine J. 2006;15:312–6.

Article  PubMed Central  Google Scholar 

Gruber HE, Ingram JA, Norton HJ, Hanley EN. Senescence in cells of the aging and degenerating intervertebral disc: Immunolocalization of senescence-associated β-galactosidase in human and sand rat discs. Spine. 2007;32:321–7.

Article  PubMed  Google Scholar 

Vo NV, Hartman RA, Patil PR, Risbud MV, Kletsas D, Iatridis JC, et al. Molecular mechanisms of biological aging in intervertebral discs. J Orthop Res. 2016;34:1289–306.

Binch A, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK, et al. Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther. 2014;16:416 .

Article  PubMed  Google Scholar 

Binch ALA, Cole AA, Breakwell LM, Michael ALR, Chiverton N, Creemers LB, et al. Class 3 semaphorins expression and association with innervation and angiogenesis within the degenerate human intervertebral disc. Oncotarget. 2015;6:18338–54. Available from: http://www.oncotarget.com/fulltext/4274.

Purmessur D, Freemont AJ, Hoyland JA. Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res Ther. 2008;10. Available from: https://pubmed.ncbi.nlm.nih.gov/18727839/.

Phillips KLE, Chiverton N, Michael ALR, Cole AA, Breakwell LM, Haddock G, et al. The cytokine and chemokine expression profile of nucleus pulposus cells: Implications for degeneration and regeneration of the intervertebral disc. Arthritis Res Ther. 2013;15:R213.

Phillips KLE, Cullen K, Chiverton N, Michael ALR, Cole AA, Breakwell LM, et al. Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes. Osteoarthr Cartil. 2015;23:1165–77.

Article  CAS  Google Scholar 

Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 2010;62:1974–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005;7:R732–45.

Article  PubMed  PubMed Central  Google Scholar 

Hoyland JA, Le Maitre C, Freemont AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology. 2008;47:809–14.

Article  CAS  PubMed  Google Scholar 

Gorth DJ, Shapiro IM, Risbud MV. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2019;10:7

Article  CAS  Google Scholar 

Phillips KLE, Jordan-Mahy N, Nicklin MJH, Le Maitre CL. Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Ann Rheum Dis. 2013;72:1860–7.

Article  CAS  PubMed  Google Scholar 

Swamy G, Salo P, Duncan N, Jirik F, Matyas J. IL-1Ra deficiency accelerates intervertebral disc degeneration in C57BL6J mice. JOR Spine. 2022;5. Available from: https://pubmed.ncbi.nlm.nih.gov/35783913/.

Karppinen J, Solovieva S, Luoma K, Raininko R, Leino-Arjas P, Riihimäki H. Modic changes and interleukin 1 gene locus polymorphisms in occupational cohort of middle-aged men. Eur Spine J. 2009;18:1963–70.

Article  PubMed  PubMed Central  Google Scholar 

Solovieva S, Kouhia S, Leino-Arjas P, Ala-Kokko L, Luoma K, Raininko R, et al. Interleukin 1 polymorphisms and intervertebral disc degeneration. Epidemiology. 2004;15:626–33.

Article  PubMed  Google Scholar 

Solovieva S, Lohiniva J, Leino-Arjas P, Raininko R, Luoma K, Ala-Kokko L, et al. Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ß gene polymorphisms. Eur Spine J. 2006;15:613–9.

Article  PubMed  Google Scholar 

Gorth DJ, Mauck RL, Chiaro JA, Mohanraj B, Hebela NM, Dodge GR, et al. IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro. Arthritis Res Ther. 2012;14:R179.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorth DJ, Martin JT, Dodge GR, Elliott DM, Malhotra NR, Mauck RL, et al. In vivo retention and bioactivity of IL-1ra microspheres in the rat intervertebral disc: a preliminary investigation. J Exp Orthop. 2014;1:1–5.

Article  Google Scholar 

Le MaitreHoyland, Freemont. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther. 2007;9:R83.

Article  Google Scholar 

Le Maitre CL, Freemont AJ, Hoyland JA. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol. 2006;87:17–28.

Article  PubMed  PubMed Central  Google Scholar 

Goldring SR, Goldring MB, Goldring SR. Clinical aspects, pathology and pathophysiology of osteoarthritis. J Musculoskelet Neuronal Interact. 2006;6:376–8.

CAS  PubMed  Google Scholar 

Senter R, Boyce R, Repic M, Martin EW, Chabicovsky M, Langevin-Carpentier G, et al. Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat Model. Hum Gene Ther. 2022;33:541–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang G, Evans CH, Benson JM, Hutt JA, Seagrave JC, Wilder JA, et al. Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat model. Mol Ther Methods Clin Dev. 2016;3:15052.

Article  PubMed  PubMed Central